Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
August 02, 2024 16:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
Frozen Shoulder Syndrome Global Clinical Trials Review 2024
July 31, 2024 04:09 ET
|
Research and Markets
Dublin, July 31, 2024 (GLOBE NEWSWIRE) -- The "Frozen Shoulder Syndrome - Global Clinical Trials Review, 2024" has been added to ResearchAndMarkets.com's offering.The "Frozen Shoulder Syndrome -...
Hypoglycemia Global Clinical Trials Review 2024
July 29, 2024 10:42 ET
|
Research and Markets
Dublin, July 29, 2024 (GLOBE NEWSWIRE) -- The "Hypoglycemia - Global Clinical Trials Review, 2024" has been added to ResearchAndMarkets.com's offering.The clinical trial report, "Hypoglycemia -...
EU (European Union) Clinical Trial Regulation 536/2014 Overview and Implementation Experience Training Course - November 11-12th 2024 and On-Demand
July 22, 2024 07:48 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "EU (European Union) Clinical Trial Regulation 536/2014: Overview and Implementation Experience Training Course" conference has been added to ...
Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
July 18, 2024 08:00 ET
|
Science 37, Inc.
Science 37 enrolls 65 patients per month for its sponsor's Phase 3 infectious disease clinical trial.
Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy
July 17, 2024 07:35 ET
|
ALTERITY THERAPEUTICS LIMITED
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers...
Comprehensive Global Diabetic Foot Ulcers Clinical Trials Review
July 04, 2024 07:19 ET
|
Research and Markets
Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Foot Ulcers - Global Clinical Trials Review, 2024" report has been added to ResearchAndMarkets.com's offering.The report is designed to...
Global VISTA Inhibitor Clinical Trials & Market Opportunity Insight 2024: Widening Research Purview - From Cancer to Autoimmune Disorders
July 04, 2024 04:03 ET
|
Research and Markets
Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "Global VISTA Inhibitor Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. The...
Drafting and Negotiating Clinical Trial Agreements: 1-Day Online Training Course (November 5, 2024)
July 03, 2024 11:20 ET
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "Drafting and Negotiating Clinical Trial Agreements Training Course" training has been added to ResearchAndMarkets.com's offering. The life science...
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Global Clinical Trials Review and Competitive Landscape Report 2024
July 03, 2024 04:08 ET
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Global Clinical Trials Review, 2024" clinical trials has been added to ...